CVCs are experimenting with how much mileage can be gained from emerging interfaces such as virtual reality, exoskeletons and brain-computer implants.
Month: June 2018
Interview: Roel Bulthuis, Merck
How do you feel that the venture unit has changed the parent, particularly given how long you have been at Merck? I started this venture unit as part of Merck, and as a pure-play healthcare therapeutics focused fund, investing strategically for the benefit of Merck’s pharma business. It improved the reputation of the corporate to… Continue reading Interview: Roel Bulthuis, Merck
Interview: William Taranto, Merck & Co
How has the fund changed Merck & Co, and, particularly given the length of time you have been there, what changes have you found rewarding? Not a lot has change with the fund since we started in 2010. The subtle change to the fund is around our strategy. When we first launched, the goal was… Continue reading Interview: William Taranto, Merck & Co
Health innovations push the sector forward
GCV Analytics defines the health sector as encompassing pharmaceuticals, medical and diagnostic devices, healthcare IT and administration, care provision and on-demand services as well as other health businesses.
Slight decrease in May
The number of corporate-backed rounds reported in May was 209, down slightly from the 215 in the same month last year. Total investment value fell to $8.99bn, down 4% from $9.3bn in May 2017. Compared with the first four months of 2018, May registered weaker results than March and April, with their 272 and 234… Continue reading Slight decrease in May
Pursuit of excellence is the only calling card worth carrying
June issue editorial by James Mawson, editor-in-chief
Wayra and Edinburgh combine for AI accelerator
Wayra UK, a subsidiary of telecommunications firm Telefónica, has joined University of Edinburgh to form a UK-based artificial intelligence (AI) and blockchain accelerator. The Edinburgh initiative will be Wayra’s first in Scotland and will receive assistance from state-owned economic development agency Scottish Enterprise. It will be open to spinouts and startups, and will accept 20… Continue reading Wayra and Edinburgh combine for AI accelerator
Immuta handles corporates to secure $20m
The AI data management software developer has raised money in a series B round featuring Dell Technologies Capital and Citi Ventures.
SmartAsset asserts itself in $28m series C
Citi Ventures came on board as an investor in the financial advisory platform, which also counts Ageon and New York Life as backers.
Cisco makes it to July acquisition
Indoor location software provider July Systems, which has received funding from Intel, Acer and Motorola, is set to be bought by Cisco.
Cambricon canters to nine-figure series B round
China-based artificial intelligence chipset developer Cambricon Technologies has secured hundreds of millions of dollars in series B funding from investors including e-commerce firm Alibaba, China Money Network reported today. SDIC Venture Capital, a subsidiary of state-owned investment holding firm China Reform Holdings, co-led the round with the Chinese government-owned Capital Venture Investment Fund and its… Continue reading Cambricon canters to nine-figure series B round
Stealth BioTherapeutics emerges with $100m
Stealth has secured $100m in convertible note financing across two rounds, one of which was led by Nan Fung Technology’s Pivotal Beta.
SigFig signs up for $50m
Existing investors New York Life and UBS came back for a series E round that increased the wealth management platform’s total funding to $120m.
Decibel amps up with $55m series C
Decibel Therapeutics, which is developing drugs to combat hearing loss, raised the cash in a round that included SR One, Regeneron and GV.